Log In
Print this Print this

Resolute Integrity Drug-Eluting Stent (DES) (formerly Resolute)

  Manage Alerts
Collapse Summary General Information
Company Medtronic plc
DescriptionZotarolimus-eluting coronary stent utilizing the BioLinx polymer
Molecular Target FK506 binding protein (macrophilin-12)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat de novo coronary artery lesions; Treat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today